1. Home
  2. VRNA vs CMA Comparison

VRNA vs CMA Comparison

Compare VRNA & CMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • CMA
  • Stock Information
  • Founded
  • VRNA 2005
  • CMA 1849
  • Country
  • VRNA United Kingdom
  • CMA United States
  • Employees
  • VRNA N/A
  • CMA N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • CMA Major Banks
  • Sector
  • VRNA Health Care
  • CMA Finance
  • Exchange
  • VRNA Nasdaq
  • CMA Nasdaq
  • Market Cap
  • VRNA 8.3B
  • CMA 7.7B
  • IPO Year
  • VRNA 2017
  • CMA N/A
  • Fundamental
  • Price
  • VRNA $105.18
  • CMA $66.56
  • Analyst Decision
  • VRNA Buy
  • CMA Hold
  • Analyst Count
  • VRNA 11
  • CMA 21
  • Target Price
  • VRNA $114.10
  • CMA $62.50
  • AVG Volume (30 Days)
  • VRNA 8.1M
  • CMA 3.0M
  • Earning Date
  • VRNA 08-11-2025
  • CMA 07-18-2025
  • Dividend Yield
  • VRNA N/A
  • CMA 4.26%
  • EPS Growth
  • VRNA N/A
  • CMA 15.05
  • EPS
  • VRNA N/A
  • CMA 5.21
  • Revenue
  • VRNA $118,535,000.00
  • CMA $3,215,000,000.00
  • Revenue This Year
  • VRNA $893.95
  • CMA $7.26
  • Revenue Next Year
  • VRNA $73.76
  • CMA $2.83
  • P/E Ratio
  • VRNA N/A
  • CMA $12.79
  • Revenue Growth
  • VRNA N/A
  • CMA N/A
  • 52 Week Low
  • VRNA $18.51
  • CMA $48.12
  • 52 Week High
  • VRNA $105.50
  • CMA $73.45
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 70.25
  • CMA 58.47
  • Support Level
  • VRNA $104.58
  • CMA $65.80
  • Resistance Level
  • VRNA $105.31
  • CMA $70.15
  • Average True Range (ATR)
  • VRNA 0.22
  • CMA 1.95
  • MACD
  • VRNA -0.64
  • CMA 0.05
  • Stochastic Oscillator
  • VRNA 60.49
  • CMA 64.77

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About CMA Comerica Incorporated

With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.

Share on Social Networks: